View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Atezolizumab 840 / Nab-Paclitaxel 125, Breast Cancer, neoadjuvant, cycle 1-3.
Protocol-ID: 2423 V1.0 (Mini), ATEZ840/NPAC125, Breast Ca, neoadj., C1-3Indication(s)
- Breast Cancer (tripel negative, PD-L1+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 29.08.2023